Literature DB >> 10856279

A genome-wide search for susceptibility loci to human essential hypertension.

P Sharma1, J Fatibene, F Ferraro, H Jia, S Monteith, C Brown, D Clayton, K O'Shaughnessy, M J Brown.   

Abstract

We undertook a systematic search of the entire human genome with the affected sibling-pair model to identify major susceptibility loci to essential hypertension. Affected nuclear families (n=263) were recruited and divided according to definite or probable genetic contribution to hypertension depending on number of hypertensive siblings. The largest nuclear families were first screened with a set of microsatellite markers. Regions on the genome with P<0.05 were tested against the second set of smaller families. An exclusion map was generated to identify regions in which hypertension-causing genes are unlikely to reside. Sibling-pair linkage analysis identified a single locus on chromosome 11q (P<0.004) in the first pass. A second pass with nuclear families that had only affected sibling pairs was, as expected, insufficient to support linkage to 11q. Multipoint exclusion-linkage analysis showed that 3 genetic loci are necessary to explain familial aggregation of essential hypertension. Our preliminary findings suggest that no single region within the human genome contains genes with a major contribution to essential hypertension. We show that the disease is indeed polygenic, with each gene providing a relatively small risk. Our exclusion map will help future investigators to concentrate on areas likely to contain these genes. The region on chromosome 11 is the first to point to a new candidate gene for hypertension that has arisen out of a genome search, but replication of these results at a higher significance is necessary before positional cloning can be justified.

Entities:  

Mesh:

Year:  2000        PMID: 10856279     DOI: 10.1161/01.hyp.35.6.1291

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Matching the right drug to the right patient in essential hypertension.

Authors:  M J Brown
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

2.  Genomewide scans of complex human diseases: true linkage is hard to find.

Authors:  J Altmüller; L J Palmer; G Fischer; H Scherb; M Wjst
Journal:  Am J Hum Genet       Date:  2001-09-14       Impact factor: 11.025

3.  Genome-wide linkage and positional candidate gene study of blood pressure response to dietary potassium intervention: the genetic epidemiology network of salt sensitivity study.

Authors:  Tanika N Kelly; James E Hixson; Dabeeru C Rao; Hao Mei; Treva K Rice; Cashell E Jaquish; Lawrence C Shimmin; Karen Schwander; Chung-Shuian Chen; Depei Liu; Jichun Chen; Concetta Bormans; Pramila Shukla; Naveed Farhana; Colin Stuart; Paul K Whelton; Jiang He; Dongfeng Gu
Journal:  Circ Cardiovasc Genet       Date:  2010-09-22

4.  A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study.

Authors:  Sue Rutherford; Guowen Cai; Juan C Lopez-Alvarenga; Jack W Kent; V Saroja Voruganti; J Michael Proffitt; Joanne E Curran; Mathew P Johnson; Thomas D Dyer; Jeremy B Jowett; Raul A Bastarrachea; Larry D Atwood; Harald H H Goring; Jean W Maccluer; Eric K Moses; John Blangero; Anthony G Comuzzie; Shelley A Cole
Journal:  Am J Hum Genet       Date:  2007-08-20       Impact factor: 11.025

Review 5.  The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.

Authors:  Hania K Flaten; Andrew A Monte
Journal:  Cardiovasc Drugs Ther       Date:  2017-08       Impact factor: 3.727

6.  Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension.

Authors:  Gregory C Amberg; Adrian D Bonev; Charles F Rossow; Mark T Nelson; Luis F Santana
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Epidemiology of essential hypertension: the role of genetic polymorphism.

Authors:  V Romano-Spica; M Mettimano; A Ianni; M L Specchia; G Ricciardi; L Savi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Mapping loci influencing blood pressure in the Framingham pedigrees using model-free LOD score analysis of a quantitative trait.

Authors:  Jo Knight; Bernard V North; Pak C Sham; David Curtis
Journal:  BMC Genet       Date:  2003-12-31       Impact factor: 2.797

9.  Emilin1 gene and essential hypertension: a two-stage association study in northern Han Chinese population.

Authors:  Chong Shen; Xiangfeng Lu; Yun Li; Qi Zhao; Xiaoli Liu; Liping Hou; Laiyuan Wang; Shufeng Chen; Jianfeng Huang; Dongfeng Gu
Journal:  BMC Med Genet       Date:  2009-11-18       Impact factor: 2.103

10.  Microsatellites and SNPs linkage analysis in a Sardinian genetic isolate confirms several essential hypertension loci previously identified in different populations.

Authors:  Evelina Mocci; Maria P Concas; Manuela Fanciulli; Nicola Pirastu; Mauro Adamo; Valentina Cabras; Cristina Fraumene; Ivana Persico; Alessandro Sassu; Andrea Picciau; Dionigio A Prodi; Donatella Serra; Ginevra Biino; Mario Pirastu; Andrea Angius
Journal:  BMC Med Genet       Date:  2009-08-28       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.